Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Pediatric Hematology/Oncology|November 2, 2020
Very Late Relapse in Pediatric Acute Myeloid Leukemia: A Case Report and Brief Literature ReviewGraham D Unis, Nathan VanderVeen, Matthew Fletcher, et al.
Clinical Genitourinary Cancer|September 27, 2021
Combination Therapy With Bortezomib in Renal Medullary Carcinoma: A Case SeriesAlixandra Ryan, Karine Tawagi, Nathan VanderVeen, et al.
Journal of Community Health|August 9, 2019
Perceived Barriers and Trends in HPV Vaccination via Patient Survey Responses at Kalamazoo, Michigan's Federally-Qualified Health CenterNathan VanderVeen, Arika Wieneke, Samantha Tran, et al.
Annals of Vascular Surgery|January 17, 2020
Improving Inferior Vena Cava Filter Retrieval and Success Rates Using an Office Endovascular CenterNathan VanderVeen, Jeffrey Friedman, Mark Rummel, et al.
Idcases|November 19, 2020
Encephalitis with coinfection by Jamestown canyon virus (JCV) and varicella zoster virus (VZV)Nathan VanderVeen, Nikki Nguyen, Kenny Hoang, et al.
Human Gene Therapy. Clinical Development|September 7, 2013
Effectiveness and preclinical safety profile of doxycycline to be used "off-label" to induce therapeutic transgene expression in a phase I clinical trial for gliomaNathan VanderVeen, Christopher Paran, Jonathan Krasinkiewicz, et al.
Human Gene Therapy Methods|April 9, 2016
Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma ModelNathan VanderVeen, Nicholas Raja, Elizabeth Yi, et al.
Molecular Therapy. Methods & Clinical Development|July 29, 2014
Marmosets as a preclinical model for testing "off-label" use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectorsNathan VanderVeen, Christopher Paran, Ashley Appelhans, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 4, 2014
Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapyHikmat H Assi, Chris Paran, Nathan VanderVeen, et al.
Toxicology and Applied Pharmacology|February 14, 2013
Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaMariana Puntel, Ghulam Muhammad A K M, Catherine Farrokhi, et al.
Pageof 1